151 related articles for article (PubMed ID: 19937113)
21. Retroviral DNA Integration.
Lesbats P; Engelman AN; Cherepanov P
Chem Rev; 2016 Oct; 116(20):12730-12757. PubMed ID: 27198982
[TBL] [Abstract][Full Text] [Related]
22. Divalent cations stimulate preferential recognition of a viral DNA end by HIV-1 integrase.
Yi J; Asante-Appiah E; Skalka AM
Biochemistry; 1999 Jun; 38(26):8458-68. PubMed ID: 10387092
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of HIV-1 integrase by modified oligonucleotides derived from U5' LTR.
Snásel J; Rejman D; Liboska R; Tocík Z; Ruml T; Rosenberg I; Pichová I
Eur J Biochem; 2001 Feb; 268(4):980-6. PubMed ID: 11179964
[TBL] [Abstract][Full Text] [Related]
24. Virtual screening application of a model of full-length HIV-1 integrase complexed with viral DNA.
Liao C; Karki RG; Marchand C; Pommier Y; Nicklaus MC
Bioorg Med Chem Lett; 2007 Oct; 17(19):5361-5. PubMed ID: 17719223
[TBL] [Abstract][Full Text] [Related]
25. The HIV-1 integrase α4-helix involved in LTR-DNA recognition is also a highly antigenic peptide element.
Azzi S; Parissi V; Maroun RG; Eid P; Mauffret O; Fermandjian S
PLoS One; 2010 Dec; 5(12):e16001. PubMed ID: 21209864
[TBL] [Abstract][Full Text] [Related]
26. HIV integrase as a target for antiviral chemotherapy.
Nair V
Rev Med Virol; 2002; 12(3):179-93. PubMed ID: 11987143
[TBL] [Abstract][Full Text] [Related]
27. An unusual helix turn helix motif in the catalytic core of HIV-1 integrase binds viral DNA and LEDGF.
Merad H; Porumb H; Zargarian L; René B; Hobaika Z; Maroun RG; Mauffret O; Fermandjian S
PLoS One; 2009; 4(1):e4081. PubMed ID: 19119323
[TBL] [Abstract][Full Text] [Related]
28. Structural determinants for HIV-1 integrase inhibition by beta-diketo acids.
Marchand C; Zhang X; Pais GC; Cowansage K; Neamati N; Burke TR; Pommier Y
J Biol Chem; 2002 Apr; 277(15):12596-603. PubMed ID: 11805103
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of human immunodeficiency virus type 1 concerted integration related to strand transfer inhibition and drug resistance.
Zahm JA; Bera S; Pandey KK; Vora A; Stillmock K; Hazuda D; Grandgenett DP
Antimicrob Agents Chemother; 2008 Sep; 52(9):3358-68. PubMed ID: 18591263
[TBL] [Abstract][Full Text] [Related]
30. Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor.
Quashie PK; Han YS; Hassounah S; Mesplède T; Wainberg MA
PLoS One; 2015; 10(6):e0128310. PubMed ID: 26046987
[TBL] [Abstract][Full Text] [Related]
31. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.
Hazuda DJ; Felock P; Witmer M; Wolfe A; Stillmock K; Grobler JA; Espeseth A; Gabryelski L; Schleif W; Blau C; Miller MD
Science; 2000 Jan; 287(5453):646-50. PubMed ID: 10649997
[TBL] [Abstract][Full Text] [Related]
32. Peptide HIV-1 integrase inhibitors from HIV-1 gene products.
Suzuki S; Urano E; Hashimoto C; Tsutsumi H; Nakahara T; Tanaka T; Nakanishi Y; Maddali K; Han Y; Hamatake M; Miyauchi K; Pommier Y; Beutler JA; Sugiura W; Fuji H; Hoshino T; Itotani K; Nomura W; Narumi T; Yamamoto N; Komano JA; Tamamura H
J Med Chem; 2010 Jul; 53(14):5356-60. PubMed ID: 20586421
[TBL] [Abstract][Full Text] [Related]
33. Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides.
Brodin P; Pinskaya M; Buckle M; Parsch U; Romanova E; Engels J; Gottikh M; Mouscadet JF
Biochemistry; 2002 Feb; 41(5):1529-38. PubMed ID: 11814346
[TBL] [Abstract][Full Text] [Related]
34. Pre-organized structure of viral DNA at the binding-processing site of HIV-1 integrase.
Renisio JG; Cosquer S; Cherrak I; El Antri S; Mauffret O; Fermandjian S
Nucleic Acids Res; 2005; 33(6):1970-81. PubMed ID: 15814814
[TBL] [Abstract][Full Text] [Related]
35. Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.
Di Santo R; Costi R; Roux A; Artico M; Lavecchia A; Marinelli L; Novellino E; Palmisano L; Andreotti M; Amici R; Galluzzo CM; Nencioni L; Palamara AT; Pommier Y; Marchand C
J Med Chem; 2006 Mar; 49(6):1939-45. PubMed ID: 16539381
[TBL] [Abstract][Full Text] [Related]
36. A three-dimensional model of the human immunodeficiency virus type 1 integration complex.
Wielens J; Crosby IT; Chalmers DK
J Comput Aided Mol Des; 2005 May; 19(5):301-17. PubMed ID: 16184433
[TBL] [Abstract][Full Text] [Related]
37. Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1.
Cherepanov P; Esté JA; Rando RF; Ojwang JO; Reekmans G; Steinfeld R; David G; De Clercq E; Debyser Z
Mol Pharmacol; 1997 Nov; 52(5):771-80. PubMed ID: 9351967
[TBL] [Abstract][Full Text] [Related]
38. [HIV-1 integrase inhibition by dimeric bisbenzimidazoles having different spacers].
Korolev SP; Tashlitskiĭ VN; Smolov MA; Gromyko AV; Zhuze AL; Agapkina IuIu; Gottikh MB
Mol Biol (Mosk); 2010; 44(4):718-27. PubMed ID: 20873232
[TBL] [Abstract][Full Text] [Related]
39. Novel HIV integrase inhibitors with anti-HIV activity: insights into integrase inhibition from docking studies.
Cox AG; Nair V
Antivir Chem Chemother; 2006; 17(6):343-53. PubMed ID: 17249248
[TBL] [Abstract][Full Text] [Related]
40. The HIV-1 integrase monomer induces a specific interaction with LTR DNA for concerted integration.
Pandey KK; Bera S; Grandgenett DP
Biochemistry; 2011 Nov; 50(45):9788-96. PubMed ID: 21992419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
